Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,519 JPY | +1.67% | +2.64% | +6.90% |
04-18 | Nxera Pharma Initiates Restricted Stock Unit Plans, Starting with Shares Worth 164 Million Yen in Total in May | MT |
04-17 | Nxera Pharma's Neuro Drug NBI-1117568 Passed Preclinical Toxicity Test | MT |
Evolution of the average Target Price on Nxera Pharma Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Nxera Pharma Co., Ltd.
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- 4565 Stock
- Consensus Nxera Pharma Co., Ltd.